These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 8823531)

  • 1. Molecular genetics of hyperparathyroid disease.
    Tominaga Y; Takagi H
    Curr Opin Nephrol Hypertens; 1996 Jul; 5(4):336-41. PubMed ID: 8823531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular pathogenesis of primary hyperparathyroidism.
    Cetani F; Pardi E; Borsari S; Marcocci C
    J Endocrinol Invest; 2011 Jul; 34(7 Suppl):35-9. PubMed ID: 21985978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperparathyroidism in hereditary syndromes: special expressions and special managements.
    Marx SJ; Simonds WF; Agarwal SK; Burns AL; Weinstein LS; Cochran C; Skarulis MC; Spiegel AM; Libutti SK; Alexander HR; Chen CC; Chang R; Chandrasekharappa SC; Collins FS
    J Bone Miner Res; 2002 Nov; 17 Suppl 2():N37-43. PubMed ID: 12412776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of parathyroid tumourigenesis in uraemia.
    Tominaga Y
    Nephrol Dial Transplant; 1999; 14 Suppl 1():63-5. PubMed ID: 10048455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequency of somatic MEN1 gene mutations in monoclonal parathyroid tumours of patients with primary hyperparathyroidism.
    Miedlich S; Krohn K; Lamesch P; Müller A; Paschke R
    Eur J Endocrinol; 2000 Jul; 143(1):47-54. PubMed ID: 10870030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Familial hyperparathyroidism: report of a case.
    Abe H; Tani T; Naito H; Mekata E; Sako H; Ioka J; Kodama M
    Surg Today; 1999; 29(1):63-6. PubMed ID: 9934834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular pathogenesis of primary hyperparathyroidism.
    Arnold A; Shattuck TM; Mallya SM; Krebs LJ; Costa J; Gallagher J; Wild Y; Saucier K
    J Bone Miner Res; 2002 Nov; 17 Suppl 2():N30-6. PubMed ID: 12412775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular pathology of parathyroid tumors.
    Carling T
    Trends Endocrinol Metab; 2001 Mar; 12(2):53-8. PubMed ID: 11167122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clonal analysis of nodular parathyroid hyperplasia in renal hyperparathyroidism.
    Tominaga Y; Kohara S; Namii Y; Nagasaka T; Haba T; Uchida K; Numano M; Tanaka Y; Takagi H
    World J Surg; 1996 Sep; 20(7):744-50; discussion 750-2. PubMed ID: 8678945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progression of uremic hyperparathyroidism involves allelic loss on chromosome 11.
    Falchetti A; Bale AE; Amorosi A; Bordi C; Cicchi P; Bandini S; Marx SJ; Brandi ML
    J Clin Endocrinol Metab; 1993 Jan; 76(1):139-44. PubMed ID: 8421078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetics of endocrine and metabolic disorders: parathyroid.
    Thakker RV
    Rev Endocr Metab Disord; 2004 Mar; 5(1):37-51. PubMed ID: 14966388
    [No Abstract]   [Full Text] [Related]  

  • 12. Studies in a kindred with parathyroid carcinoma.
    Streeten EA; Weinstein LS; Norton JA; Mulvihill JJ; White BJ; Friedman E; Jaffe G; Brandi ML; Stewart K; Zimering MB
    J Clin Endocrinol Metab; 1992 Aug; 75(2):362-6. PubMed ID: 1639936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutational analysis of the extracellular Ca(2+)-sensing receptor gene in human parathyroid tumors.
    Hosokawa Y; Pollak MR; Brown EM; Arnold A
    J Clin Endocrinol Metab; 1995 Nov; 80(11):3107-10. PubMed ID: 7593409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Etiologies of parathyroid gland dysfunction in primary hyperparathyroidism.
    Marx SJ
    J Bone Miner Res; 1991 Oct; 6 Suppl 2():S19-24; discussion S31-2. PubMed ID: 1684885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A case of familial isolated hyperparathyroidism with ectopic parathyroid cancer.
    Yamashita K; Suzuki S; Yumita W; Ikeo Y; Uehara Y; Minemura K; Sakurai A; Hashizume K
    Endocr J; 2001 Aug; 48(4):453-8. PubMed ID: 11603567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple endocrine neoplasia type 1 (MEN1) germline mutations in familial isolated primary hyperparathyroidism.
    Pannett AA; Kennedy AM; Turner JJ; Forbes SA; Cavaco BM; Bassett JH; Cianferotti L; Harding B; Shine B; Flinter F; Maidment CG; Trembath R; Thakker RV
    Clin Endocrinol (Oxf); 2003 May; 58(5):639-46. PubMed ID: 12699448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Chromosome abnormalities in hyperparathyroidism: utility of comparative genomic hybridization in the study of parathyroid hyperplasias].
    Afonso S; Cigudosa JC; Santamaría I; Otero A; Menárguez J; García Miranda JL
    Nefrologia; 2003; 23 Suppl 2():2-6. PubMed ID: 12778845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic defects associated with familial and sporadic hyperparathyroidism.
    Hendy GN; Cole DE
    Front Horm Res; 2013; 41():149-65. PubMed ID: 23652676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple endocrine neoplasia type 1 (MEN1) gene mutations in a subset of patients with sporadic and familial primary hyperparathyroidism target the coding sequence but spare the promoter region.
    Karges W; Jostarndt K; Maier S; Flemming A; Weitz M; Wissmann A; Feldmann B; Dralle H; Wagner P; Boehm BO
    J Endocrinol; 2000 Jul; 166(1):1-9. PubMed ID: 10856877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential loss of heterozygosity in familial, sporadic, and uremic hyperparathyroidism.
    Farnebo F; Teh BT; Dotzenrath C; Wassif WS; Svensson A; White I; Betz R; Goretzki P; Sandelin K; Farnebo LO; Larsson C
    Hum Genet; 1997 Mar; 99(3):342-9. PubMed ID: 9050920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.